• Explore /
  • Poster
  • / A phase 1b/2 trial of pepinemab and avelumab as second line therapy for patients with metastatic pancreatic adenocarcinoma.

A phase 1b/2 trial of pepinemab and avelumab as second line therapy for patients with metastatic pancreatic adenocarcinoma.

Abstract Poster

Authors

null

Bailey Hilty

University of Rochester Cancer Center & Wilmot Cancer Institute, Rochester, NY

Bailey Hilty , Luis I. Ruffolo , Brian A. Belt , Matthew Byrne , Yatee A. Dave , Paul R. Burchard , Terrence Lee Fisher , Elizabeth E. Evans , Crystal L. Mallow , Megan Boise , Maurice Zauderer , Daniel Mulkerin , Jen Jen Yeh , David Linehan

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Gastrointestinal Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT05102721

Citation

J Clin Oncol 42, 2024 (suppl 3; abstr TPS712)

DOI

10.1200/JCO.2024.42.3_suppl.TPS712

Abstract #

TPS712

Poster Bd #

Q1

Abstract Disclosures

Similar Posters

First Author: J. Randolph Hecht

First Author: Syvart Dennen

First Author: Luis I. Ruffolo

First Author: Peter C. Thuss-Patience